EU criticises 'hasty' UK approval of Covid-19 vaccine
Skip to main content
  • Home
  • Economy
  • Stocks
  • Analysis
  • World+Biz
  • Sports
  • Features
  • Epaper
  • More
    • Subscribe
    • COVID-19
    • Bangladesh
    • Splash
    • Videos
    • Games
    • Long Read
    • Infograph
    • Interviews
    • Offbeat
    • Thoughts
    • Podcast
    • Quiz
    • Tech
    • Archive
    • Trial By Trivia
    • Magazine
    • Supplement
  • বাংলা
The Business Standard

Saturday
July 02, 2022

Sign In
Subscribe
  • Home
  • Economy
  • Stocks
  • Analysis
  • World+Biz
  • Sports
  • Features
  • Epaper
  • More
    • Subscribe
    • COVID-19
    • Bangladesh
    • Splash
    • Videos
    • Games
    • Long Read
    • Infograph
    • Interviews
    • Offbeat
    • Thoughts
    • Podcast
    • Quiz
    • Tech
    • Archive
    • Trial By Trivia
    • Magazine
    • Supplement
  • বাংলা
SATURDAY, JULY 02, 2022
EU criticises 'hasty' UK approval of Covid-19 vaccine

Coronavirus chronicle

Reuters
03 December, 2020, 08:50 am
Last modified: 03 December, 2020, 08:54 am

Related News

  • EU’s REX system: Exporters now enjoy hassle-free certification of goods origin
  • UK sends military experts to counter Russian influence in Bosnia and Herzegovina
  • Bangladesh requests UK for resettlement of 100,000 Rohingyas
  • US, Japan, Australia, New Zealand and United Kingdom form Pacific group
  • Boris Johnson under pressure after UK election defeats

EU criticises 'hasty' UK approval of Covid-19 vaccine

The European Medicines Agency (EMA) said its longer approval procedure was more appropriate as it was based on more evidence and required more checks than the emergency procedure chosen by Britain

Reuters
03 December, 2020, 08:50 am
Last modified: 03 December, 2020, 08:54 am
Representational image. Photo: Collected
Representational image. Photo: Collected

The European Union criticised Britain's rapid approval of Pfizer and BioNTech's Covid-19 vaccine on Wednesday, saying its own procedure was more thorough, after Britain became the first western country to endorse a Covid-19 shot.

The move to grant emergency authorisation to the Pfizer/BioNTech vaccine has been seen by many as a political coup for UK Prime Minister Boris Johnson, who has led his country out of the EU and faced criticism for his handling of the pandemic.

The decision was made under an ultra-fast, emergency approval process, which allowed the British drugs regulator to temporarily authorise the vaccine only 10 days after it began examining data from large-scale trials.

In an unusually blunt statement, the European Medicines Agency (EMA), which is in charge of approving Covid-19 vaccines for the EU, said its longer approval procedure was more appropriate as it was based on more evidence and required more checks than the emergency procedure chosen by Britain.

The agency said on Tuesday it would decide by Dec. 29 whether to provisionally authorise the vaccine from U.S. drugmaker Pfizer Inc and its German partner BioNTech SE .

A spokesman for the European Commission, the EU executive, said the EMA's procedure was "the most effective regulatory mechanism to grant all EU citizens' access to a safe and effective vaccine," as it was based on more evidence.

Pfizer UK Country Manager Ben Osborn said, "We have provided complete data packages, the unblinded data, to both regulators. I think what you're seeing is just the difference in the underlying process and timelines, as opposed to any difference in data submission."

June Raine, the head of Britain's Medicines and Healthcare products Regulatory Agency (MHRA), said, "The way in which the MHRA has worked is equivalent to all international standards.

"Our progress has been totally dependent on the availability of data in our rolling review and our rigorous assessment and independent advice we have received," she added.

The EMA started a rolling review of preliminary data from Pfizer trials on Oct. 6, an emergency procedure aimed at speeding up possible approval, which usually takes at least seven months from reception of full data.

The UK regulator launched its own rolling review on Oct. 30, and analysed less data than made available to the EMA.

"The idea is not to be first but to have a safe and effective vaccine," Germany's Health Minister Jens Spahn told a news conference.

Asked about the emergency procedure used by Britain, he said EU countries had opted for a more thorough procedure to boost confidence in vaccines.

"If you evaluate only the partial data as they are doing they also take a minimum of risk," the EMA's former head Guido Rasi told an Italian radio.

"Personally I would have expected a robust review of all available data, which the British government has not done to be able to say that without Europe you come first," he added.

'Problematic'

EU lawmakers were even more explicit in their criticism of Britain's move.

"I consider this decision to be problematic and recommend that EU Member States do not repeat the process in the same way," said Peter Liese, an EU lawmaker who is a member of German Chancellor Angela Merkel's party.

"A few weeks of thorough examination by the European Medicines Agency is better than a hasty emergency marketing authorisation of a vaccine," said Liese, who represents the centre right grouping, the largest in the EU Parliament.

Under EU rules, the Pfizer vaccine must be authorised by the EMA, but EU countries can use an emergency procedure that allows them to distribute a vaccine at home for temporary use.

Britain is still subject to EU rules until it fully leaves the bloc at the end of the year.

"There is an obvious global race to get the vaccine on the market as fast as possible," said Tiemo Wolken, an EU lawmaker from the socialist grouping, the second largest in the Parliament.

"However, I do believe that it is better to take the time and make sure that the quality, effectiveness and safety is guaranteed and matches our EU standards."

Top News

UK / Coronavirus Vaccine / covid-19 vaccine / coronavirus in UK / UK-EU / European Union / European Medicines Agency (EMA)

Comments

While most comments will be posted if they are on-topic and not abusive, moderation decisions are subjective. Published comments are readers’ own views and The Business Standard does not endorse any of the readers’ comments.

Top Stories

  • In rain, heat, filth – they fight against cancer
    In rain, heat, filth – they fight against cancer
  • Tejgaon Industrial Area has become an illegal parking lot for all kinds of vehicles, from buses to trucks to rickshaws. Photo: Mumit M
    Rickshaw garages and truck stands: How Tejgaon Industrial Area turned into a mess
  • TBS Illustration
    Universities may launch online classes again after Eid

MOST VIEWED

  • Former North Korean defectors living in South Korea, release balloons containing one dollar banknotes, radios, CDs and leaflets denouncing the North Korean regime, towards the north near the demilitarized zone which separates the two Koreas in Paju, north of Seoul January 15, 2014. REUTERS/Kim Hong-Ji/File Photo
    North Korea blames 'alien things' near border with South for Covid outbreak
  • People wearing protective face masks commute amid concerns over the new coronavirus disease (COVID-19) in Pyongyang, North Korea March 30, 2020, in this photo released by Kyodo. Picture taken March 30, 2020. Mandatory credit Kyodo/via REUTERS
    S Korea says leaflets sent by defectors unlikely to be cause of Covid in N Korea
  • Test tubes are seen in front of displayed Pfizer and Biontech logos in this illustration taken, May 21, 2021. Reuters: llustration
    BioNTech, Pfizer to start testing universal vaccine for coronaviruses
  • A woman holds a small bottle labelled with a "Coronavirus COVID-19 Vaccine" sticker and a medical syringe in this illustration taken October 30, 2020. REUTERS/Dado Ruvic/File Photo
    S Korea approves first domestically developed Covid vaccine
  • Photo: Collected
    US medical experts call for Omicron-specific Covid boosters
  • David E Adler. Sketch: TBS
    Who managed Covid-19 best, and why?

Related News

  • EU’s REX system: Exporters now enjoy hassle-free certification of goods origin
  • UK sends military experts to counter Russian influence in Bosnia and Herzegovina
  • Bangladesh requests UK for resettlement of 100,000 Rohingyas
  • US, Japan, Australia, New Zealand and United Kingdom form Pacific group
  • Boris Johnson under pressure after UK election defeats

Features

The eye-catching commuter: Suzuki Gixxer SF 155

The eye-catching commuter: Suzuki Gixxer SF 155

1h | Wheels
Photo: Collected

Sapiens – A Graphic History 

23h | Book Review
Black-naped Monarch male  Photo: Enam Ul Haque

Black-naped Monarch: A sovereign who never abandoned the Indian subcontinent

1d | Panorama
The 136-year-old company on its last legs

The 136-year-old company on its last legs

1d | Features

More Videos from TBS

Dhaka University celebrating 102nd founding anniversary today

Dhaka University celebrating 102nd founding anniversary today

22h | Videos
Ctg Int'l Trade Fair returns after a 2-year hiatus without Covid restrictions

Ctg Int'l Trade Fair returns after a 2-year hiatus without Covid restrictions

23h | Videos
Bangladeshis among top 6 nationalities seeking asylum in Europe

Bangladeshis among top 6 nationalities seeking asylum in Europe

1d | Videos
RUET organises Robotronics 2.0

RUET organises Robotronics 2.0

1d | Videos

Most Read

1
Padma Bridge from satellite. Photo: Screengrab
Bangladesh

Padma Bridge from satellite 

2
Meet the man behind 'Azke amar mon balo nei'
Splash

Meet the man behind 'Azke amar mon balo nei'

3
Photo: TBS
Bangladesh

Motorcycles banned on Padma Bridge 

4
Photo: Collected
Economy

Tech startup ShopUp bags $65m in Series B4 funding

5
World Bank to give Bangladesh $18b IDA loans in next five years
Economy

World Bank to give Bangladesh $18b IDA loans in next five years

6
Investor Hiru fined Tk2cr for market manipulation
Stocks

Investor Hiru fined Tk2cr for market manipulation

EMAIL US
contact@tbsnews.net
FOLLOW US
WHATSAPP
+880 1847416158
The Business Standard
  • About Us
  • Contact us
  • Sitemap
  • Privacy Policy
  • Comment Policy
Copyright © 2022
The Business Standard All rights reserved
Technical Partner: RSI Lab
BENEATH THE SURFACE
The Dazzling Fake Flowers: Is there any alternative to artificial flowers while decorating homes, showrooms, offices and business establishments? Fresh flowers are undoubtedly beautiful, but they dry out quickly. Hence, the demand for plastic flowers is rising day by day. Traders said these lifelike silk flowers usually come from China and Thailand. The photo was taken from the 29th International Trade Fair of the Chattogram Chamber on Friday. PHOTO: Mohammad Minhaj Uddin

Contact Us

The Business Standard

Main Office -4/A, Eskaton Garden, Dhaka- 1000

Phone: +8801847 416158 - 59

Send Opinion articles to - oped.tbs@gmail.com

For advertisement- sales@tbsnews.net